Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GOLIMUMAB Cause Multiple organ dysfunction syndrome? 18 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Multiple organ dysfunction syndrome have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.0% of all adverse event reports for GOLIMUMAB.

18
Reports of Multiple organ dysfunction syndrome with GOLIMUMAB
0.0%
of all GOLIMUMAB reports
16
Deaths
8
Hospitalizations

How Dangerous Is Multiple organ dysfunction syndrome From GOLIMUMAB?

Of the 18 reports, 16 (88.9%) resulted in death, 8 (44.4%) required hospitalization, and 1 (5.6%) were considered life-threatening.

Is Multiple organ dysfunction syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 18 reports have been filed with the FAERS database.

What Other Side Effects Does GOLIMUMAB Cause?

Drug ineffective (17,959) Rheumatoid arthritis (12,272) Pain (11,443) Fatigue (9,626) Off label use (8,764) Alopecia (8,394) Rash (8,331) Joint swelling (8,264) Arthralgia (7,968) Abdominal discomfort (7,902)

What Other Drugs Cause Multiple organ dysfunction syndrome?

TACROLIMUS (1,847) CYCLOPHOSPHAMIDE (1,597) MYCOPHENOLATE MOFETIL (1,566) PREDNISONE (1,525) DEXAMETHASONE (1,355) METHOTREXATE (1,317) METHYLPREDNISOLONE (1,278) RITUXIMAB (1,188) PREDNISOLONE (1,154) CYCLOSPORINE (933)

Which GOLIMUMAB Alternatives Have Lower Multiple organ dysfunction syndrome Risk?

GOLIMUMAB vs GOLODIRSEN GOLIMUMAB vs GONADORELIN GOLIMUMAB vs GONADOTROPHIN, CHORIONIC GOLIMUMAB vs GOSERELIN GOLIMUMAB vs GRAMICIDIN

Related Pages

GOLIMUMAB Full Profile All Multiple organ dysfunction syndrome Reports All Drugs Causing Multiple organ dysfunction syndrome GOLIMUMAB Demographics